Ricardo Fierro-Medina

Ricardo Fierro-Medina

Auto-generated profile, based on publicly available information

Ricardo Fierro-Medina

Departamento de Química Universidad Nacional de Colombia Carrera 45 No 26 ‐ 85, Building 451 Bogotá 11321 Colombia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2020 in RSC Advances
Verified
Journal Article
Open access
PDF file
NANatalia Ardila-Chantré
Natalia Ardila-Chantré
AHAngie Katherine Hernández-Cardona
Angie Katherine Hernández-Cardona
HPHéctor Pineda-Castañeda
Héctor Pineda-Castañeda
SESandra Mónica Estupiñan-Torres
Sandra Mónica Estupiñan-Torres
ALAura Lucía Leal-Castro
Aura Lucía Leal-Castro
JCJavier Garcia Castañeda
Javier Garcia Castañeda
Short peptides derived from buforin and lactoferricin B were conjugated with other antimicrobial molecules of different chemical natures. The sequences RLLR, RLLRLLR, RWQWRWQWR, and RRWQWR were conjugated at their N-terminal end with non-peptidic molecules such as 6-aminohexanoic acid, ferrocene, caffeic acid, ferulic acid, and oxolinic acid. Peptide conjugates and unmodified peptides were synthesized by means of solid-phase peptide synthesis using the Fmoc/tBu strategy (SPPS-Fmoc/tBu), purified via RP-SPE, and characterized via RP-HPLC and MS. The peptides' antibacterial activity against bacterial strains E. coli ATCC 25922 and S. aureus ATCC 25923 was evaluated, and the results showed that the peptide conjugates exhibited higher antibacterial activity than the original unconjugated peptides. Conjugation of AMPs is a promising strategy for designing and identifying new drugs for treating bacterial infections.

27 September 2024
Verified
Journal Article
Open access
PDF file
NANatalia Ardila-Chantré
Natalia Ardila-Chantré
Claudia Marcela Marcela Parra-GiraldoClaudia Marcela Marcela Parra-Giraldo
Claudia Marcela Marcela Parra-Giraldo
Yerly Vargas-CasanovaYerly Vargas-Casanova
Yerly Vargas-Casanova
ACAndrea Barragán Cárdenas
Andrea Barragán Cárdenas
RFRicardo Fierro-Medina
Ricardo Fierro-Medina
JCJavier Garcia Castañeda
Javier Garcia Castañeda
Aim: The aim of this research was to generate new peptide molecules with cytotoxic activity against cervical cancer that can become effective in mitigating the impact of the disease and preventing its progression. The design is based on the hybrid peptide formation strategy that allows new chemical entities to be obtained from the union of fragments of different bioactive peptides. Specifically, we worked by combining the RWQWRWQWR sequence derived from bovine lactoferricin with different functional peptides such as anticancer peptides, cervical cancer cell-targeting peptides, and cell-penetrating peptides. Methods: Hybrid peptides and precursors were synthesized by solid-phase peptide synthesis using the Fmoc/tBu strategy, purified via reverse phase (RP)-solid phase extraction, and characterized by RP-high performance liquid chromatography (RP-HPLC) chromatography and mass spectrometry. In vitro cytotoxicity of hybrid peptides in human cervical cancer cells lines HeLa and Ca Ski was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Results: All hybrid peptides were obtained with high purity and the experimental mass corresponds with the theoretical mass. Some hybrid peptides exhibited significant, fast, and selective cytotoxic activity against the cancerous cells evaluated, specifically those containing sequences of anticancer peptides and cell-penetrating peptides. The cytotoxic effect exerted by the monomeric and dimeric hybrid peptides depended on the concentration of the peptide, which allowed the determination of the IC50 values and the selectivity index (SI). Conclusions: We obtained hybrid peptides with the core sequence RWQWRWQWR that are active against HeLa and Ca Ski cell lines. The combination of the RWQWRWQWR sequence with short anticancer peptides and cell-penetrating peptides allowed the creation of hybrid peptides with improved cytotoxic potency against cervical cancer. Hybrid peptides constitute a novel, viable, and useful strategy for the design and identification of peptide drugs with anticancer activity.

26 February 2025
Verified
Journal Article
Open access
PDF file
KCKaren Cárdenas-Martínez
Karen Cárdenas-Martínez
JRJuan Esteban Reyes-Calderón
Juan Esteban Reyes-Calderón
Claudia Marcela Marcela Parra-GiraldoClaudia Marcela Marcela Parra-Giraldo
Claudia Marcela Marcela Parra-Giraldo
Yerly Vargas-CasanovaYerly Vargas-Casanova
Yerly Vargas-Casanova
ACAndrea Barragán Cárdenas
Andrea Barragán Cárdenas
JCJavier Garcia Castañeda
Javier Garcia Castañeda
Aim: To identify peptides derived from bovine lactoferricin (LfcinB) as potential therapeutics for colon cancer treatment. We systematically modified dimeric peptides to enhance their selectivity against colon cancer cells and reduce toxicity. We examined the effects of specific changes, such as substituting L-arginine (Arg) with L-ornithine (Orn) and/or D-Arg, on cytotoxic activity in colon cancer cells, as well as activity in prostate and cervical cancer cell lines. Additionally, we assessed the type of cell death induced and the in vivo toxicity of the dimeric peptides. Methods: The peptides were synthesized by manual solid-phase peptide synthesis, purified by reverse phase-solid phase extraction (RP-SPE), and characterized by RP-high performance liquid chromatography (RP-HPLC), and mass spectrometry (MS). Their cytotoxic effect on cancer and non-cancerous cells was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The most promising dimeric peptide underwent scale-up synthesis to yield approximately 1 g. The type of induced cell death was analyzed through cytometry assays, while preliminarily toxicity studies were conducted in Galleria mellonella, zebrafish, and CD1 mice. Results: Our findings demonstrated that dimeric peptides containing L-Orn or D-Arg residues exhibited potent and selective cytotoxic effects against colon cancer cells (Caco-2 and HT-29), prostate cancer cells (DU-145), and cervical adenocarcinoma (HeLa). Notably, these modified peptides showed minimal toxicity in human erythrocytes, HEK 293 cells or fibroblasts, and Galleria mellonella larvae. Peptide 3: (R-Orn-WQWRFKKLG)2-K-Ahx, emerged as particularly promising, preserving its integrity and anticancer activity during scaled-up synthesis. Furthermore, peptide 3 induced behavioral changes and sedation in CD1 mice and showed significantly lower toxicity in zebrafish. Conclusions: The results suggested that specific modifications of Arg/Orn residues in dimeric peptides enhance their cytotoxicity against colon cancer cells and reduce in vivo toxicity. These modified peptides hold promise as safe and effective therapeutic candidates, potentially expanding the treatment options available for cancer.

11 July 2025 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
DADaniel Alejandro Castellar Almonacid
Daniel Alejandro Castellar Almonacid
ACAndrea Barragán Cárdenas
Andrea Barragán Cárdenas
KRKarla Geraldine Rodríguez-Mejia
Karla Geraldine Rodríguez-Mejia
LMLaura Angélica Maldonado-Sanabria
Laura Angélica Maldonado-Sanabria
NANatalia Ardila-Chantré
Natalia Ardila-Chantré
RFRicardo Fierro-Medina
Ricardo Fierro-Medina
Previous studies show that the palindromic peptide RWQWRWQWR, derived from bovine lactoferricin (LfcinB), exhibits selective in vitro cytotoxicity against cervical, breast, and prostate cancer cells.

7 December 2020 in Current Organic Chemistry
Verified
Journal Article
Closed access
PDF file
TRTatiana Román
Tatiana Román
DRDavid Ramirez
David Ramirez
RFRicardo Fierro-Medina
Ricardo Fierro-Medina
RSRosa Santillan
Rosa Santillan
NFNorberto Farfan
Norberto Farfan
Organometallic complexes are an important class of synthetic reagents and are of great interest due to their versatility and wide biological application. The cationic nature of the coordination nucleus facilitates its interaction with biological molecules such as amino acids, proteins, and nucleic acids. The functionalization of peptides or amino acids with organometallic motifs is a novel strategy for the design and development of molecules with greater biological activity, stability in biological environments, and selectivity for specific targets, which make them valuable tools for designing and obtaining molecules with therapeutic applications. The physicochemical properties of ferrocene make it ideal for drug development, due to its structure, stability in aqueous solutions, redox properties, and low toxicity. In the same way, organotin (IV) derivatives have great potential for drug development because of their multiple biological activities, wide structural versatility, high degree of stability, and low toxicity. However, the synthesis of these drugs based on organometallic molecules containing ferrocene or organotin (IV) is quite complex and represents a challenge nowadays; for this reason, it is necessary to design and implement procedures to obtain molecules with a high degree of purity, in sufficient quantities, and at low cost. This review describes the strategies of synthesis used up to now for the preparation of organometallic amino acids and peptides containing ferrocene or organotin (IV) derivates, as well as their impact on the development of therapeutic agents.

9 September 2023 in Biomedical Chromatography
Verified
Journal Article
Closed access
NLNicolás Mateo González López
Nicolás Mateo González López
LGLuisa María Guerra‐Acero‐Turizo
Luisa María Guerra‐Acero‐Turizo
IBIsabella Blanco‐Medina
Isabella Blanco‐Medina
ACAndrea Barragán Cárdenas
Andrea Barragán Cárdenas
DRDavid Augusto Ramírez‐Celis
David Augusto Ramírez‐Celis
ZMZuly Jenny Rivera Monroy
Zuly Jenny Rivera Monroy